Provident Partners has been engaged by biowave Neurostimulation medical device to assist in identifying license opportunities for the product outside of the US. This follows Provident initiatives in supporting the development of a new biowave OTC entry. Biowave is a patented, FDA approved device that effectively eliminates chronic and injury related musco skeletal pain. It is an alternative to opioids that is safe, non-habit forming, and proven to provide long lasting relief. The device is currently used throughout the professional sports segment, 160 collegiate sports programs, VA Hospitals and pain clinics. The Workers Comp market represents a major untapped opportunity to the Company.